A workplace testing policy that relies on an objective measure for drug use supports fairness in the workplace and, ultimately, provides employers with protection against risks.

Implementing policies around impairment may cause employers to lose sight of the primary goal of workplace drug testing – detecting and deterring workday use.

Conventional cannabis testing methods and outdated policies in the era of cannabis legalization are contributing to an upside-down effect of non-negative results.

Originally designed to detect and deter workplace drug use, the evolution of testing programs has resulted in a limited scope which decreases its efficacy.

Overhauling workplace cannabis testing policies is imperative if companies want to future-proof their operations, maintain safety, and retain employees.

How do a bathroom scale and a fitness app relate to a successful and sustainable drug testing program? By preventing unexpected surprises.

Modernizing the definition of safety-sensitive is critical for employers when maximizing the benefits of their drug testing program.

Custody and Control of a specimen are critical to supporting the defensibility of a workplace drug test; however, many people just consider it pesky paperwork.

2022 New Year’s Resolution for Employers: Invest more in your EAP or create one as part of a comprehensive drug testing policy if you do not currently offer one.

Post-hire testing detects and deters on-the-job cannabis use while keeping personal choices private.

Cannabis breath testing will help to usher in a new era of social equity in workplace drug testing with permanent changes that prioritize both safety and fair treatment of all employees.

I have attended several conferences over the last couple of months and have noticed a new and recurring theme – social equity. I am excited that leaders in the drug testing and safety industries recognize the importance of these conversations and the need to examine and improve current practices.